C Schmoor

Summary

Affiliation: University of Freiburg
Country: Germany

Publications

  1. ncbi request reprint Role of isolated locoregional recurrence of breast cancer: results of four prospective studies
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany
    J Clin Oncol 18:1696-708. 2000
  2. ncbi request reprint Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Germany
    Breast Cancer Res Treat 54:31-8. 1999
  3. ncbi request reprint Sample size considerations for the evaluation of prognostic factors in survival analysis
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan Meier Str 26, D 79104 Freiburg, Germany
    Stat Med 19:441-52. 2000
  4. ncbi request reprint Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany
    Int J Cancer 86:408-15. 2000
  5. ncbi request reprint Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan Meier Str 26, D 79104, Freiburg, Germany
    Eur J Cancer 37:1123-31. 2001
  6. ncbi request reprint Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study Group
    W Sauerbrei
    Institute of Medical Biometry, University of Freiburg, Freiburg, Germany
    J Clin Oncol 18:94-101. 2000
  7. pmc Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)
    W Sauerbrei
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Germany
    Br J Cancer 79:1752-60. 1999
  8. ncbi request reprint Assessment and comparison of prognostic classification schemes for survival data
    E Graf
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan Meier Strasse 26, D 79104 Freiburg, Germany
    Stat Med 18:2529-45. 1999
  9. ncbi request reprint Validation of existing and development of new prognostic classification schemes in node negative breast cancer. German Breast Cancer Study Group
    W Sauerbrei
    Institute of Medical Biometry and Informatics, University of Freiburg, Germany
    Breast Cancer Res Treat 42:149-63. 1997
  10. ncbi request reprint [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials]
    G Dreier
    Universitatsklinikum, Freiburg
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 48:445-52. 2005

Detail Information

Publications14

  1. ncbi request reprint Role of isolated locoregional recurrence of breast cancer: results of four prospective studies
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany
    J Clin Oncol 18:1696-708. 2000
    ..Using data from four prospective studies of the German Breast Cancer Study Group, we investigated factors influencing prognosis after ILRR and defined a simple classification of patients into groups with different prognoses...
  2. ncbi request reprint Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Germany
    Breast Cancer Res Treat 54:31-8. 1999
    ..A valid treatment comparison is only possible by means of large randomized trials. Clinicians should participate in the ongoing trials and enter all eligible patients...
  3. ncbi request reprint Sample size considerations for the evaluation of prognostic factors in survival analysis
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan Meier Str 26, D 79104 Freiburg, Germany
    Stat Med 19:441-52. 2000
    ..This extends the formula for independent effects. Finally, the approach is illustrated by an example on the prognostic impact of DNA ploidy and other factors in advanced ovarian cancer...
  4. ncbi request reprint Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Freiburg, Germany
    Int J Cancer 86:408-15. 2000
    ..For EFS and BCS, a tendency in favour of radiotherapy is observed, but this is not significant; for OS, no difference can be demonstrated, but the power of the study is too low to detect small treatment effects...
  5. ncbi request reprint Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF
    C Schmoor
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan Meier Str 26, D 79104, Freiburg, Germany
    Eur J Cancer 37:1123-31. 2001
    ..From the usual factors investigated in this study, the PR status showed the strongest effect, and, at least this factor should be taken into account in the design and analysis of trials for breast cancer patients with a poor prognosis...
  6. ncbi request reprint Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study Group
    W Sauerbrei
    Institute of Medical Biometry, University of Freiburg, Freiburg, Germany
    J Clin Oncol 18:94-101. 2000
    ....
  7. pmc Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)
    W Sauerbrei
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Germany
    Br J Cancer 79:1752-60. 1999
    ..We conclude that analysis using fractional polynomials can extract important prognostic information which the traditional approaches may miss...
  8. ncbi request reprint Assessment and comparison of prognostic classification schemes for survival data
    E Graf
    Institute of Medical Biometry and Medical Informatics, University of Freiburg, Stefan Meier Strasse 26, D 79104 Freiburg, Germany
    Stat Med 18:2529-45. 1999
    ..In addition, they can be used to derive R(2)-type measures of explained residual variation. A breast cancer study will serve for illustration throughout the paper...
  9. ncbi request reprint Validation of existing and development of new prognostic classification schemes in node negative breast cancer. German Breast Cancer Study Group
    W Sauerbrei
    Institute of Medical Biometry and Informatics, University of Freiburg, Germany
    Breast Cancer Res Treat 42:149-63. 1997
    ..Because the measures of separation give an overoptimistic impression for the new proposals, a validation with other studies is necessary before a general recommendation can be given...
  10. ncbi request reprint [The 12th amendment to the German Drug Law. Chances and obstacles for investigator-initiated clinical trials]
    G Dreier
    Universitatsklinikum, Freiburg
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 48:445-52. 2005
    ..In the end, the directive may serve as a stimulus to build a better national research environment and to promote public funding, and may lead to fewer but more valid clinical trials...
  11. doi request reprint Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML
    P Christopoulos
    Allogeneic Stem Cell Transplantation Section, Department of Hematology Oncology, University Medical Centre Freiburg, Freiburg, Germany
    Bone Marrow Transplant 48:901-7. 2013
    ..Further modifications and a better understanding of the underlying biology could help lower the risk of relapse...
  12. ncbi request reprint Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin
    J Finke
    Department of Haematology and Oncology, Albert Ludwigs University Hospital, Freiburg, Germany
    Br J Haematol 111:303-13. 2000
    ..Our results are similar to data obtained after matched sibling donor transplantation...
  13. doi request reprint Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial
    M Dettenkofer
    Division of Infection Control and Hospital Epidemiology, Department of Environmental Health Sciences, University Medical Center Freiburg, Freiburg, Germany
    Clin Microbiol Infect 16:600-6. 2010
    ..This randomized controlled trial supports the results of two observational studies demonstrating octenidine in alcoholic solution to be a better option than alcohol alone for the prevention of CVC-associated infections...
  14. ncbi request reprint Long-term follow-up of patients in four prospective studies of the German Breast Cancer Study Group (GBSG): A summary of key results
    C Schmoor
    Institut für Medizinische Biometrie und Medizinische Informatik, Universitatsklinikum Freiburg, Germany
    Onkologie 25:143-50. 2002
    ..Overall, it can be concluded that the GBSG studies have made valuable and internationally recognized contributions to the prognosis and treatment of patients with early breast cancer...